Literature DB >> 16869299

[14-3-3 proteins--a role in the regulation of melatonin biosynthesis].

Jolanta Rosiak1, Jolanta Barbara Zawilska.   

Abstract

14-3-3 proteins compose a large family of proteins that exist primarily as homo- and heterodimers within all eukaryotic cells. They are engaged in the regulation of numerous cellular processes, including melatonin biosynthesis. Melatonin, the hormone of darkness, is synthesized in a diurnal or circadian rhythm, with high levels at night. It has been demonstrated that cAMP levels and PKA activity in melatonin-synthesizing cells (pinealocytes and retinal photoreceptors) increase at night. PKA phosphorylates serotonin N-acetyltransferase (AANAT; the penultimate and key regulatory enzyme in melatonin biosynthesis pathway) at its N- (Thr31) and C-(Ser205)terminal region. Phosphorylated of AANAT bind to 14-3-3 proteins. The formation of pAANAT/14-3-3 complex stabilizes the enzyme and protects it against proteolytic destruction. Furthermore, this complex induces allosteric changes of the AANAT molecule resulting in an increase of the enzyme activity; this in turn enhances melatonin production by several fold. Exposure to light at night decreases intracellular cAMP level with concomitant dephosphorylation of pAANAT, its dissociation from 14-3-3 dimers, proteosomal proteolysis of free AANAT molecules, and finally turning off the melatonin production.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16869299

Source DB:  PubMed          Journal:  Postepy Biochem        ISSN: 0032-5422


  2 in total

1.  Alterations in melatonin and 5-HT signalling in the colonic mucosa of mice with dextran-sodium sulfate-induced colitis.

Authors:  Sarah J MacEachern; Catherine M Keenan; Evangelia Papakonstantinou; Keith A Sharkey; Bhavik Anil Patel
Journal:  Br J Pharmacol       Date:  2018-03-25       Impact factor: 8.739

2.  Effects of PACAP on the circadian changes of signaling pathways in chicken pinealocytes.

Authors:  Boglarka Racz; Gabriella Horvath; Nandor Faluhelyi; Andras D Nagy; Andrea Tamas; Peter Kiss; Ferenc Gallyas; Gabor Toth; Balazs Gaszner; Valer Csernus; Dora Reglodi
Journal:  J Mol Neurosci       Date:  2008-07-01       Impact factor: 3.444

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.